Content area
Full Text
Sensyne Health, the UK healthcare artificial intelligence company, has priced its IPO on London’s alternative investment market (AIM), valuing it at £225m when it begins trading on Friday.
Peel Hunt was bookrunner. The deal consisted of 34.28m new shares, at a fixed offer price of 175p a share, making the IPO worth £60m.
There was large demand from a range of institutional investors including generalist funds, mid-cap funds, and artificial intelligence specialists.
“That is where the interest ended up at,” said a source close to the deal. “There...